Department of Cardiology, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland; 3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.
3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland
Kardiol Pol. 2020 Apr 24;78(4):318-324. doi: 10.33963/KP.15242. Epub 2020 Mar 19.
European and American guidelines for the placement of implantable cardioverter‑defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT‑D) in patients with heart failure (HF) remain unchanged despite controversy and ongoing debate on the etiology of HF. However, there are limited data on the long‑term follow‑up in patients who received primary defibrillator therapy with regard to ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM). The prognostic significance of the etiology of HF is not well established.
The aim of the study was to assess the predictive value of the cause of HF.
A total of 1073 patients with the first implantation of ICD/CRT‑D between January 2009 and December 2013 from the COMMIT‑HF (Contemporary Modalities In Treatment of Heart Failure) registry were selected for the study. Patients were divided into 2 groups depending on the etiology of HF: ischemic (n = 705; 65.7%) and nonischemic (n = 368; 34.3%). The primary endpoint was long‑term all‑cause mortality.
The median follow‑up was 60.5 months. The primary endpoint occurred more often in the ICM as compared with the NICM group (35.7% vs 26.6%; P = 0.008). A higher out‑of‑hospital mortality in patients with ICM tended to be statistically significant (15.5% vs 10.6; P = 0.05). The multivariate analysis revealed that, among others, an ischemic etiology of HF was an independent factor of long‑term mortality (hazard ratio, 1.43; 95% CI, 1.30-1.81; P = 0.003). Other independent predictors for mortality are: age older than 65 years, impaired left ventricular ejection fraction, chronic kidney disease, atrial fibrillation, diabetes mellitus.
In the real‑world population, significantly worse survival of patients with ICM in comparison with those with NICM is observed, and an ischemic etiology of HF is a strong independent predictor of mortality among individuals following the placement of ICD/ CRT‑D.
尽管对心力衰竭(HF)的病因仍存在争议和持续争论,但欧美指南对植入式心脏复律除颤器(ICD)和心脏再同步治疗除颤器(CRT-D)在心力衰竭患者中的放置仍保持不变。然而,对于接受原发性除颤器治疗的缺血性心肌病(ICM)和非缺血性心肌病(NICM)患者,长期随访的数据有限。HF 病因的预后意义尚未确定。
本研究旨在评估 HF 病因的预测价值。
从 2009 年 1 月至 2013 年 12 月的 COMMIT-HF(当代心力衰竭治疗模式)注册中心中选择了 1073 例首次植入 ICD/CRT-D 的患者进行研究。根据 HF 的病因将患者分为 2 组:缺血性(n=705;65.7%)和非缺血性(n=368;34.3%)。主要终点是长期全因死亡率。
中位随访时间为 60.5 个月。与 NICM 组相比,ICM 组的主要终点发生频率更高(35.7%比 26.6%;P=0.008)。ICM 患者的院外死亡率较高,有统计学意义(15.5%比 10.6%;P=0.05)。多变量分析显示,HF 的缺血性病因是长期死亡率的独立因素(危险比,1.43;95%置信区间,1.30-1.81;P=0.003)。其他独立的死亡预测因素包括:年龄大于 65 岁、左心室射血分数降低、慢性肾脏病、心房颤动、糖尿病。
在真实世界人群中,与 NICM 患者相比,ICM 患者的生存率明显较差,HF 的缺血性病因是 ICD/CRT-D 植入后个体死亡率的一个强有力的独立预测因素。